Showing results (271-280 of 372) with videos related to
Sort By:
Pageof 38
Neurology|March 10, 2010
Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophyJ Montes, M P McDermott, W B Martens, et al.Brain : a Journal of Neurology|March 22, 2023
Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural historyTyler Rehbein, Tong Tong Wu, Simona Treidler, et al.Journal of Neuromuscular Diseases|February 11, 2020
RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study DesignRichard S Finkel, John W Day, Darryl C De Vivo, et al.Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.Journal of Neuromuscular Diseases|April 25, 2022
Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional PerformanceKavya S Nair, Donovan J Lott, Sean C Forbes, et al.Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.Neurology|June 28, 2023
Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth DiseaseGabrielle A Donlevy, Kayla M D Cornett, Sarah P Garnett, et al.Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.Pageof 38